PTC Therapeutics, Inc. (PTCT): Price and Financial Metrics
PTC Therapeutics, Inc. (PTCT)
Today's Latest Price: $63.99 USD
Updated Nov 27 1:00pm
Add PTCT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
PTCT Stock Summary
- Of note is the ratio of Ptc Therapeutics Inc's sales and general administrative expense to its total operating expenses; only 17.98% of US stocks have a lower such ratio.
- With a price/sales ratio of 12.18, Ptc Therapeutics Inc has a higher such ratio than 87.38% of stocks in our set.
- In terms of twelve month growth in earnings before interest and taxes, Ptc Therapeutics Inc is reporting a growth rate of 74.92%; that's higher than 85.56% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Ptc Therapeutics Inc are FOLD, BCRX, CLSN, LOGC, and DCPH.
- PTCT's SEC filings can be seen here. And to visit Ptc Therapeutics Inc's official web site, go to www.ptcbio.com.
PTCT Stock Price Chart Interactive Chart >
PTCT Price/Volume Stats
| Current price | $63.99 | 52-week high | $64.62 |
| Prev. close | $63.53 | 52-week low | $30.79 |
| Day low | $63.27 | Volume | 245,400 |
| Day high | $64.61 | Avg. volume | 734,630 |
| 50-day MA | $54.33 | Dividend yield | N/A |
| 200-day MA | $50.47 | Market Cap | 4.37B |
PTC Therapeutics, Inc. (PTCT) Company Bio
PTC Therapeutics is a global biopharmaceutical company focused on the discovery, development and commercialization of orally administered, proprietary small molecule drugs targeting an area of RNA biology we refer to as post-transcriptional control. The company was founded in 1998 and is based in South Plainfield, New Jersey.
Loading social stream, please wait...